New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides

Claudio Santi,Luca Sancineto,Francesca Mangiavacchi,Agnieszka Dąbrowska,Agata Pacuła,Magdalena Obieziurska-Fabisiak,Cecilia Scimmi,Ying Lei,Juan Kong,Yao Zhao,Gianluca Ciancaleoni,Vanessa Nascimento,Anna Kula-Pacurar,Haitao Yang,Jacek Ścianowski,Krzysztof Pyrc,Veronica Ceccucci,Bruno Rizzuti

DOI: https://doi.org/10.26434/chemrxiv-2024-0jxr0-v2

2024-03-12

Abstract:Although global vaccination campaigns relieved the SARS-CoV-2 pandemic in terms of morbidity and mortality, the capability of the virus to originate mutants may reduce vaccines efficiency, posing a serious risk to fall into the pandemic again. As a result, there is the need to develop small molecules able to tackle conserved viral targets, such as the main protease (Mpro). Here a series of benzisoselenazolones and diselenides were tested for their ability to inhibit Mpro, then, for the most potent compounds, the antiviral activity was measured in vitro, and the mechanism of action was investigated. Density functional theory and molecular docking procedures were also implemented to shed a light into the protein/compound interaction. Finally, a bioorganic model was set up to investigate the reaction between selenorganic compounds and biologically relevant thiols, to unravel possible metabolic pathways of such compounds. The overall results contribute to identify a series of novel compounds active against SARS-CoV-2, and to clarify some important aspects in the mechanisms of action of Se-containing inhibitors targeting the SARS-CoV-2 main protease (Mpro).

Chemistry

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of novel inhibitors targeting the SARS-CoV-2 main protease (Mpro). Although global vaccination campaigns have somewhat alleviated the health threat posed by the SARS-CoV-2 pandemic, viral mutations may lead to reduced vaccine efficacy, potentially causing new outbreaks. Therefore, researchers need to develop small molecule compounds that target conserved viral sites to tackle this challenge. This paper primarily investigates a series of benzoselenazolones and diselenides as potential Mpro inhibitors and tests their antiviral activity through in vitro experiments to explore their mechanisms of action. Additionally, methods such as density functional theory and molecular docking are employed to further elucidate the interactions between these compounds and the protein. The ultimate goal is to identify a series of new compounds effective against SARS-CoV-2 and to clarify some important aspects of the mechanism of action of selenium-containing inhibitors targeting Mpro.